Investors had a volatile end to January as they weighed the Federal Reserve's pause on rate cuts, a busy earnings season and the prospect of new tariffs.Given these dynamics and the volatility in the stock market, it could be difficult for investors to pick the right stocks for their portfolios. Tracking the recommendations of top analysts could be helpful in this regard, as they look beyond short-term noise and focus on companies' long-term growth potential.With that in mind, here are three stocks favored ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive Surgical, Inc. (Exact name of Registrant as specified in its Charter) (State or Other Jurisdiction ...

Over the past decade, Intuitive Surgical (ISRG -0.39%) has proven to be a long-term winner in the healthcare sector. The stock is up more than 950% in that time frame, and more than 60% over the past year.The maker of the da Vinci robotic-assisted surgery reported soaring revenue among its fourth-quarter results. Let's examine those recent results, along with the launch of Intuitive's newest da Vinci system, to help see whether the stock's momentum can continue.Revenue surgesThe fourth quarter continued the ...

During the fourth quarter, Intuitive Surgical (ISRG) placed 493 systems, up 19% from 415 in the year-ago period. Total system placements were record-high in the past year.  This includes 284 systems placed in the United States (up 75 systems year over year) and 209 systems outside the country (up slightly from 206 a year ago).Product-wise, placements comprised 174 of the latest da Vinci 5 systems, 69 Ion systems (57% Y/Y growth) and 30 SP systems (94% Y/Y growth). These figures demonstrate robust year-over- ...

POLAND - 2024/11/19: In this photo illustration, the Intuitive Surgical company logo is seen ... [+] displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesIntuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 bill ...

Latest donation brings total contribution to more than $170 millionSUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation’s mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere. This l ...

Market Cap and Growth Potential - Companies with market caps below $1 trillion but with plausible chances of reaching that milestone could deliver excellent returns to long-term investors [1] - Intuitive Surgical currently has a market cap of $215 billion and would need a compound annual growth rate of 10 8% to reach $1 trillion by 2040 [2] Industry Leadership and Technology - Robotic-assisted surgeries offer benefits such as less bleeding, less scarring, faster recoveries, and shorter hospital stays compared to traditional open surgeries [3] - Intuitive Surgical's da Vinci system is the market leader in robotic-assisted surgical equipment with a 57% market share and an installed base of 9,539 systems as of Q3 2024, a 15% year-over-year increase [4] Growth Opportunities - Less than 5% of eligible surgeries were performed robotically as of early 2023, but this percentage could reasonably rise to 20%, representing a quadrupling of the business even if the total number of surgeries remains static [6] - The aging global population further supports long-term growth potential for robotic-assisted surgeries [6] Competitive Advantages - Intuitive Surgical has a first-mover advantage, having already developed and gained regulatory clearance for its devices, unlike competitors such as Johnson & Johnson and Medtronic [8] - High switching costs for hospitals due to significant investments in da Vinci systems and staff training create a strong moat for the company [9] - The company is an innovator, making strides in artificial intelligence and continuously improving its da Vinci system, which helps maintain its leadership position [10] Historical Performance and Future Outlook - Intuitive Surgical's compound annual growth rate over the past 25 years has been more than double what it needs to achieve to become a trillion-dollar stock by 2040 [12] - The company possesses qualities such as a strong moat, strong growth avenues, and industry leadership, making it an excellent long-term investment in the healthcare sector [12]

Shares of Intuitive Surgical (ISRG -3.58%) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates, which can often trigger a sell-off for growth stocks.As of 10:20 a.m. ET on Friday, the stock was down 3.9% on the news. Intuitive Surgical delivers strong resultsLike clockwork, the maker of the da Vinci surgical robots delivered another strong round of growth up ...

Intuitive Surgical (ISRG) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.21, which beat the Zacks Consensus Estimate of $1.65 by 24.9%. The bottom line improved 38.1% year over year.GAAP EPS in the quarter was $1.88, up 11.2% from the year-ago quarter’s level.Revenue DetailsThis Zacks Rank #3 (Hold) company reported revenues of $2.41 billion, up 24.9% year over year reportedly and 26% at constant currency (cc). A higher number of installed systems and growth in the da Vinci procedure v ...

Financial Data and Key Metrics - No specific financial data or key metrics changes mentioned in the provided content [1][2][3] Business Line Data and Key Metrics - No specific business line data or key metrics changes mentioned in the provided content [1][2][3] Market Data and Key Metrics - No specific market data or key metrics changes mentioned in the provided content [1][2][3] Company Strategy and Industry Competition - No specific company strategy or industry competition details mentioned in the provided content [1][2][3] Management Commentary on Operating Environment and Future Outlook - No specific management commentary on the operating environment or future outlook mentioned in the provided content [1][2][3] Other Important Information - Dan Connolly will be joining Intuitive as VP and Head of Investor Relations in early February, bringing 18 years of experience from a global investment manager and active following of surgical robotics since 2008 [2] - Comments on the call may contain forward-looking statements, and actual results may differ materially from those expressed or implied [3] Q&A Session - No Q&A session details provided in the content [1][2][3]